Moreover, an expanding body of evidence implicates TREM2 in the dynamics of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), which conspire to forge an immunosuppressive tumor microenvironment, thereby influencing tumor progression and outcomes (11). This evidence concerns the gene TREM2 and neoplasm.